-
AN ECONOMIC MODEL TO ESTIMATE THE 1-YEAR COSTS AND OUTCOMES IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH ENZALUTAMIDE PLUS RADIUM-223 (RA-223) OR LUTETIUM-177 VIPIVOTIDE TETRAXETAN (177LU-PSMA-617...
Feb 25, 2026, 14:41 PM -
SPONSOR VIEWS ON HARMONIZING EARLY FEASIBILITY STUDY ASSESSMENT IN THE EU: EARLY INTERACTION, PREDICTABLE TIMELINES, AND STREAMLINED PROCESS FOR SPONSOR AND DECISION-MAKERS
Feb 25, 2026, 14:41 PM -
ASSOCIATIONS OF STRUCTURAL POSITION AND HIV TESTING WITH GUIDELINE-CONCORDANT CERVICAL CANCER SCREENING AMONG U.S. WOMEN AT HIGH RISK OF HIV INFECTION
Feb 25, 2026, 14:41 PM -
USER EVALUATION OF AN AGENTIC AI ASSISTANT FOR REAL-WORLD EVIDENCE FEASIBILITY ANALYSIS
Feb 25, 2026, 14:41 PM -
BUDGET IMPACT ANALYSIS OF IMPROVED SAFETY AND EFFICACY WITH ACALABRUTINIB, BENDAMUSTINE, AND RITUXIMAB IN TRANSPLANT-INELIGIBLE, PREVIOUSLY UNTREATED MCL
Feb 25, 2026, 14:41 PM -
IMPACT OF USING RELATIVE DOSE INTENSITY VERSUS INDIVIDUAL PATIENT DOSING: A CASE STUDY USING BELANTAMAB MAFODOTIN DATA FROM THE DREAMM-7 STUDY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
Feb 25, 2026, 14:41 PM -
BEYOND QALYS: ALTERNATIVE COST-EFFECTIVENESS MEASURES IN ICER REPORTS FROM 2019 TO 2025
Feb 25, 2026, 14:41 PM -
THE IMPACT OF CARING FOR THEIR CHILDREN WITH RETT SYNDROME: A MULTI-METHOD STUDY
Feb 25, 2026, 14:41 PM -
CHARACTERIZING ONCOLOGY PATIENT JOURNEYS AND HEALTH STATE TRANSITIONS USING A DATA-DRIVEN MARKOV TRANSITION MATRIX IN LARGE-SCALE ELECTRONIC HEALTH RECORDS
Feb 25, 2026, 14:41 PM -
GUIDING RECORD LINKAGE METHOD (RL) SELECTION IN HEOR: A TARGETED REVIEW AND STRUCTURED DECISION FRAMEWORK
Feb 25, 2026, 14:41 PM -
A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE
Feb 25, 2026, 14:41 PM -
A NOVEL APPROACH FOR GENERATING ROBUST POPULATION ESTIMATES FOR USE IN HTA AND REGULATORY SUBMISSIONS: DEMONSTRATION IN CLL IN GERMANY
Feb 25, 2026, 14:41 PM -
COMPARATIVE ANALYSIS OF THE EPIDEMIOLOGICAL BURDEN OF STROKE IN EASTERN, CENTRAL AND WESTERN EUROPE BASED ON GLOBAL BURDEN OF DISEASE STUDY DATA
Feb 25, 2026, 14:41 PM -
HOSPITAL COSTS AND HEALTHCARE UTILIZATION RESOURCES OF INVASIVE FUNGAL DISEASE IN CHINA: A RETROSPECTIVE REAL WORLD STUDY
Feb 25, 2026, 14:41 PM -
THIRTY YEARS OF THE ECHO MODEL: A BIBLIOMETRIC ANALYSIS OF ITS GLOBAL INFLUENCE ON HEALTH ECONOMICS AND OUTCOMES RESEARCH
Feb 25, 2026, 14:41 PM -
CLINICAL AND HUMANISTIC BURDEN OF ADULT PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 WITH PLEXIFORM NEUROFIBROMA IN THE REAL-WORLD SETTING ACROSS FOUR EUROPEAN COUNTRIES: RESULTS FROM A REAL-WORLD SURVEY
Feb 25, 2026, 14:41 PM -
A STUDY ON ASSESSMENT OF RISK FACTORS, COMPLICATIONS AND CLINICAL EFFICACY OF HEPATOPROTECTIVES IN LIVER DISEASE
Feb 25, 2026, 14:41 PM -
ASSESSING CONCENTRATION IN THE MONOCLONAL ANTIBODY INNOVATION MARKET: A PATENT-BASED STUDY
Feb 25, 2026, 14:41 PM -
PREFERENCES FOR LONG-ACTING PREP SIDE EFFECTS AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
DEVELOPING A PATIENT-REPORTED OUTCOME (PRO) MEASURE FOR JAPANESE PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC)
Feb 25, 2026, 14:41 PM
